Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 67 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
BCX7353 for prevention of acute attacks of angioedema in hereditary angioedema	BCX7353 (Berotralstat; ORLADEYO)	Hereditary angioedema (HAE)	Genetic Disorders , Immunology	2019	View \| Download
Belimumab (subcutaneous injection) add-on for systemic lupus erythematosus in children aged 5 to 17 years old	Belimumab (Benlysta; Lymphostat-B)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2022	View \| Download
Belimumab for lupus nephritis	Belimumab (Benlysta; Lymphostat-B)	Lupus nephritis	Immunology , Nephrology	2019	View \| Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE)	Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2021	View \| Download
Belumosudil for graft versus host disease	Belumosudil (SLx-2119; KD025; KD-025)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download
Benegrastim for treating chemotherapy-induced neutropenia in women with breast cancer	Benegrastim	Breast cancer	Breast Cancer , Immunology , Toxicology	2022	View \| Download
Benralizumab for treating hypereosinophilic syndrome	Benralizumab (Fasenra; MEDI563)	Hypereosinophilic syndrome (HES)	Immunology	2023	View \| Download
Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitis	Benralizumab (Fasenra; MEDI563)	Eosinophilic granulomatosis with polyangiitis	Cardiovascular System , Immunology	2022	View \| Download
Betula verrucosa for tree pollen allergy-induced moderate to severe rhinoconjunctivitis	Birch allergy vaccine (ALK tree AIT; Betula Verrucosa allergen extract)	Tree pollen allergy	Immunology	2021	View \| Download
BPX‐501 to improve Immune Recovery and Graft versus Host Disease (GvHD) after Haploidentical Stem Cell Transplant	Rivogenlecleucel (BPX-501)	Graft versus host disease (GvHD) , Immunodeficiency	Immunology	2018	View \| Download